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rotations positioning during the treatment of MCM using 
VMAT. 
Materials and Methods: Eight treatments of MCM were 
randomly selected from the internal database. These were 
re-planned for single and multiple isocenters (S-iso; M-iso) 
VMAT. The prescription was set to 18Gy at 99% of target 
volume. Paddick conformity index (CI), V100%, V90% for 
target; V4.5Gy, V9Gy, V12Gy for body; beam-on and door-to-
door times were analyzed. For each plan, three shifts (0.5°, 
1°, 2°) were applied for pitch and roll for each isocenter, 
simulating incorrect patient repositioning (1°, 2°) and 
involuntary motion during the delivery (0.5°). The shifted 
plans were recalculated with the same monitor units and 
compared to the reference ones in terms of reduction in 
target volume receiving 90% and 100% of the prescription 
dose. 
Results: A total of 43 metastases were evaluated. No 
significant differences were found in terms of CI between the 
two approaches. M-iso showed significant lower median 
V4.5Gy and V9Gy with respect to S-iso, while S-iso resulted in 
reduced beam on time (7.8±2.8 min vs. 10.4±3.2 min) and 
significant door-to-door time (16.3±2.7 min vs. 27.4±6.2 
min). Concerning the rotated plans, there was a worsening 
with rotation increasing, with median V100% reduction for 2° 
rotations of 22.5% and 2.7% for, respectively, S-iso and M-iso. 
Figure 1 reports the full data analysis on V90% and V100% in 
terms of volume loss. 
 
Figure 1: Delta volume loss for target V90% and V100% in 
function of pitch and roll rotations. 
Conclusions: Adjustments in all six dimensions, including 
unconventional pitch and roll rotations, are fundamental for 
MCM. S-iso reducing delivery time is the treatment of choice 
as the patient comfort is essential for so challenging 
patients. In case of S-iso, on-line patient monitoring during 
the delivery in 6D should be performed to avoid undesirable 
target underdosage. 
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Purpose/Objective: 60-80 patients with an extremity soft 
tissue sarcoma (ESTS) are diagnosed annually in Ireland. At 
least half will require radiotherapy pre or post-operatively. 
Accurate and reproducible patient immobilisation is essential 
for safe delivery of radiotherapy to these patients. However, 
the optimal technique remains to be determined.  
Materials and Methods: Two lower limb immobilisation 
devices are compared in this prospective study. Arm A: is an 
in-house developed device, comprising of customized foot-
orfits and footrests, fixed to the treatment couch. Arm B: is a 
similar device, but has the additional ability to elevate either 
limb independently. 
Results: Preliminary results indicate Arm A is useful for 
proximal thigh/groin sites when limb separation is necessary 
and Arm B is advantageous when treating the distal/anterior 
thigh and calf.  
Arm A: 268 ConeBeamCT (CBCT) scans were analysed on 20 
patients to date. The resultant CTV-PTV margins required for 
setup uncertainty are 0.7, 0.5 and 0.6cm for X, Y, and Z 
directions respectively.  
Arm B: 159 CBCT scans were analysed on 13 patients to date. 
The resultant CTV-PTV margins required for setup uncertainty 
are 0.6, 0.5 and 0.4cm for X, Y, and Z directions 
respectively.  
The standard deviation of the systematic error 
(reproducibility of treatment position) was less for B than for 
A in all directions. Levene’s test for equality/homogeneity of 
variances showed that the variances of the two groups were 
statistically significantly unequal in the z direction (p=.011).  
Conclusions:This research is on-going. Both techniques 
satisfactorily immobilise the lower limb, however the results 
show a smaller CTV-PTV margin could be applied for those 
patients immobilised with the Arm B device. However, at 
present both devices are required. Final results of this 
research study will be available in April 2015; 
recommendations will be made regarding an optimal 
immobilisation device.  
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Purpose/Objective: In 1996 we reported that 63% of 
specimens of mastectomy performed for a unifocal cancer 
harbour other cancer foci; 80% of these foci are in other 
quadrants. In contrast, local recurrence after a lumpectomy 
occurs mainly at the site of the original tumour. Therefore, 
we hypothesized that cancer foci in other quadrants remain 
dormant even in the absence of radiation treatment to the 
whole breast [1]. This academic insight led us to develop the 
targeted intraoperative radiotherapy (TARGIT) technique 
using the Intrabeam device. In the TARGIT A randomized trial 
(n=3451) we compared risk adapted TARGIT vs. whole breast 
radiotherapy [2]. 
Materials and Methods: Randomisation occurred either 
before surgery (Prepathology stratum: TARGIT given during 
lumpectomy) or after surgery (TARGIT given as a delayed 
procedure); the main analysis found that using TARGIT during 
